# A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

> **NCT04710290** · PHASE2,PHASE3 · UNKNOWN · sponsor: **E-DA Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Metastatic Cancer
- Chemotherapy

## Interventions

- **DIETARY_SUPPLEMENT:** Beta-Glucan
- **DIETARY_SUPPLEMENT:** Glutamine
- **DIETARY_SUPPLEMENT:** Immunoglobuin
- **DIETARY_SUPPLEMENT:** Corn starch

## Key facts

- **NCT ID:** NCT04710290
- **Lead sponsor:** E-DA Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-04
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04710290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04710290, "A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04710290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*